Olmesartan Medoxomil – Watch for These Side Effects

FDA is warning that the blood pressure drug Olmesartan Medoxomil marketed as Benicar, Benicar HCT, Azor, Tribenzor, and generics can cause intestinal problems known as sprue-like enteropathy. Symptoms of sprue-like enteropathy include severe, chronic diarrhea with substantial weight loss. FDA has approved changes to the labels of these drugs to include this concern. Sprue-like enteropathy has not been detected with ARB drugs other than olmesartan

via Safety Alerts for Human Medical Products > Olmesartan Medoxomil: Drug Safety Communication – Label Changes To Include Intestinal Problems Sprue-Like Enteropathy.

Weight Loss Surgery May Boost Problem Drinking

Almost 10% of patients undergoing bariatric surgery to combat obesity had symptoms of an alcohol use disorder 2 years after surgery, a large prospective cohort study showed.

The prevalence of alcohol use disorders increased from 7.6% before surgery to 9.6% 2 years after the procedure, as reported online in the Journal of the American Medical Association.

via Medical News: Weight Loss Surgery May Boost Problem Drinking – in Primary Care, Obesity from MedPage Today.

Have surgery, lose weight, become alcoholic!

Is Obesity a Disability?

Ruling Could Spur Hiring Bias Against Obese Workers | workforce.com

If obesity is included under the ADA, it would likely be narrowly defined to exclude a condition that is the result of a person’s lifestyle.

While there have been few cases like the one in Indiana, the growth of obesity in the workplace may lead to more workers’ compensation or discrimination cases.

If the courts recognize obesity as a disability, millions of obese Americans could potentially claim discrimination. About two-thirds of Americans are overweight, and 27 percent—about 72 million—are obese, according to data from the Centers for Disease Control and Prevention.

A doctor concluded that Childers’ back recovery was “doomed to failure” unless he lost weight. After physical therapy worsened Childers’ back pain, his doctor recommended back surgery.

The company argued that Childers’ weight constituted a pre-existing condition for which it was not responsible.

Citing a precedent in a case involving a longtime smoker, the court ruled differently. It said the employee’s pre-existing obesity, combined with his back injury and subsequent weight gain, formed a new work-related “single injury” the employer was responsible for treating.

Lap Band? Think Again

Safety and effectiveness of bariatric surgery: Roux-en-Y gastric bypass is superior to gastric banding in the management of morbidly obese patients

In summary, there is rapidly mounting and convincing evidence that laparoscopic gastric banding is suboptimal in the management of morbid obesity. Although short-term complications are low and hospital length of stay is short, the long-term problems including band removals are high and failure to lose weight after laparoscopic gastric banding is prevalent.